Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial. Has recently been published in the Lancet. The trial showed that LMWH did not result in higher livebirth rates in women who had two or more pregnancy losses and confirmed inherited thrombophilia. ALIFE2 publications can be accessed here.
The Warwick Clinical Trials Unit (WCTU) has a strong track record in delivering excellent research. Established in 2005, we received full registration status from the UKCRC in 2007.
We care about patient centred outcomes and we want to find ways to improve them. Our trials and investigations help us to do that. We're not afraid to ask the difficult questions, by leading and supporting clinical trials that seek to find answers. We have a reputation for challenging long-established norms.
Discover Our Work
Our core portfolio trials cover:
- Emergency and critical care
- Maternal Health
- Surgery/Pain and Rehabilitation
Learn more about current, recruiting and follow up trials as well as completed trials in our Trials Portfolio section.
Collaborate with us
We specialise in the development and delivery of large multicentre clinical trials.
Whether you need support for specific services or full trial management, we can help.
Discover more about the services we provide by visiting Collaborate with WCTU.
This unit receives National Institute for Health and Care Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.